| scholarly article | Q13442814 |
| P2093 | author name string | D A Portnoy | |
| A L Decatur | |||
| P433 | issue | 5493 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Listeria monocytogenes | Q292015 |
| P304 | page(s) | 992-995 | |
| P577 | publication date | 2000-11-01 | |
| P1433 | published in | Science | Q192864 |
| P1476 | title | A PEST-like sequence in listeriolysin O essential for Listeria monocytogenes pathogenicity | |
| P478 | volume | 290 |
| Q33849628 | A Genetically Modified attenuated Listeria Vaccine Expressing HPV16 E7 Kill Tumor Cells in Direct and Antigen-Specific Manner |
| Q42369903 | A Promising Listeria-Vectored Vaccine Induces Th1-Type Immune Responses and Confers Protection Against Tuberculosis |
| Q43507336 | A bacterial pore-forming toxin forms aggregates in cells that resemble those associated with neurodegenerative diseases |
| Q37079131 | A novel dendritic cell targeting HPV16 E7 synthetic vaccine in combination with PD-L1 blockade elicits therapeutic antitumor immunity in mice. |
| Q37059164 | A novel prfA mutation that promotes Listeria monocytogenes cytosol entry but reduces bacterial spread and cytotoxicity. |
| Q37143251 | A study of the ultrastructure of fragile-X-related proteins |
| Q41474918 | Actin-based motility is sufficient for bacterial membrane protrusion formation and host cell uptake |
| Q38718753 | Activity of the Pore-Forming Virulence Factor Listeriolysin O Is Reversibly Inhibited by Naturally Occurring S-Glutathionylation. |
| Q34267760 | Adjuvant properties of listeriolysin O protein in a DNA vaccination strategy. |
| Q28205820 | Alternative splice variants of doublecortin-like kinase are differentially expressed and have different kinase activities |
| Q50666420 | Alternative trans-splicing of the Trypanosoma cruzi LYT1 gene transcript results in compartmental and functional switch for the encoded protein. |
| Q36324280 | Aminopeptidase T of M29 Family Acts as A Novel Intracellular Virulence Factor for Listeria monocytogenes Infection. |
| Q61704729 | An in silico DNA vaccine against Listeria monocytogenes |
| Q36399765 | Anthrolysin O and other gram-positive cytolysins are toll-like receptor 4 agonists |
| Q34059063 | Arcanolysin is a cholesterol-dependent cytolysin of the human pathogen Arcanobacterium haemolyticum. |
| Q91890842 | Bacteria-cancer interactions: bacteria-based cancer therapy |
| Q26853146 | Biological effects of listeriolysin O: implications for vaccination |
| Q47105902 | Carboxyl-Terminal Residues N478 and V479 Required for the Cytolytic Activity of Listeriolysin O Play a Critical Role in Listeria monocytogenes Pathogenicity |
| Q34033192 | Characterization of Listeria monocytogenes expressing anthrolysin O and phosphatidylinositol-specific phospholipase C from Bacillus anthracis |
| Q39755092 | Characterization of anthrolysin O, the Bacillus anthracis cholesterol-dependent cytolysin |
| Q24534721 | Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins |
| Q35689107 | Compartmentalization of the broad-range phospholipase C activity to the spreading vacuole is critical for Listeria monocytogenes virulence |
| Q57976656 | Critical role of the N-terminal residues of listeriolysin O in phagosomal escape and virulence ofListeria monocytogenes |
| Q27690081 | Crystal structure of listeriolysin O reveals molecular details of oligomerization and pore formation |
| Q24675620 | Cytolysin-dependent escape of the bacterium from the phagosome is required but not sufficient for induction of the Th1 immune response against Listeria monocytogenes infection: distinct role of Listeriolysin O determined by cytolysin gene replacement |
| Q45862960 | Cytosolic delivery of antisense oligonucleotides by listeriolysin O-containing liposomes |
| Q33884591 | Definition of genetically distinct attenuation mechanisms in naturally virulence-attenuated Listeria monocytogenes by comparative cell culture and molecular characterization |
| Q33963180 | Dendritic cells inhibit the progression of Listeria monocytogenes intracellular infection by retaining bacteria in major histocompatibility complex class II-rich phagosomes and by limiting cytosolic growth |
| Q50564697 | Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014. |
| Q55280574 | Development of New Preventive and Therapeutic Vaccines for Tuberculosis. |
| Q37232523 | Development of a mariner-based transposon and identification of Listeria monocytogenes determinants, including the peptidyl-prolyl isomerase PrsA2, that contribute to its hemolytic phenotype |
| Q34208868 | Development of a single-gene, signature-tag-based approach in combination with alanine mutagenesis to identify listeriolysin O residues critical for the in vivo survival of Listeria monocytogenes |
| Q50700341 | Differential susceptibility of bone marrow-derived dendritic cells and macrophages to productive infection with Listeria monocytogenes. |
| Q40612429 | Drosophila S2 cells: an alternative infection model for Listeria monocytogenes |
| Q37521613 | Effects of Clostridium perfringens alpha-toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues |
| Q27314009 | Endothelial Cells Use a Formin-Dependent Phagocytosis-Like Process to Internalize the Bacterium Listeria monocytogenes |
| Q34977345 | Energy-Generating Enzymes of Burkholderia cepacia and Their Interactions with Macrophages |
| Q40450707 | Enhanced protective efficacy against tuberculosis provided by a recombinant urease deficient BCG expressing heat shock protein 70-major membrane protein-II having PEST sequence. |
| Q40612417 | Exploration of host-pathogen interactions using Listeria monocytogenes and Drosophila melanogaster |
| Q36708689 | Functional dissection of Toxoplasma gondii perforin-like protein 1 reveals a dual domain mode of membrane binding for cytolysis and parasite egress |
| Q35143267 | Haemolysin A and listeriolysin--two vaccine delivery tools for the induction of cell-mediated immunity |
| Q36469826 | Heterologous prime/boost immunization with p53-based vaccines combined with toll-like receptor stimulation enhances tumor regression. |
| Q44371772 | High-level expression of the Listeria monocytogenes listeriolysin O in Escherichia coli and preliminary characterization of the purified protein |
| Q35906097 | Immune responses to Listeria monocytogenes |
| Q57598511 | Impfung gegen Tuberkulose |
| Q40469229 | Inhibition effect of tea tree oil on Listeria monocytogenes growth and exotoxin proteins listeriolysin O and p60 secretion. |
| Q34119762 | Intracellular induction of Listeria monocytogenes actA expression |
| Q33847763 | Invasive extravillous trophoblasts restrict intracellular growth and spread of Listeria monocytogenes. |
| Q39952229 | Lactococcus lactis-expressing listeriolysin O (LLO) provides protection and specific CD8(+) T cells against Listeria monocytogenes in the murine infection model |
| Q36600365 | Listeria monocytogenes as a vector for tumor-associated antigens for cancer immunotherapy. |
| Q34796825 | Listeria monocytogenes multidrug resistance transporters activate a cytosolic surveillance pathway of innate immunity |
| Q34947257 | Listeria monocytogenes mutants that fail to compartmentalize listerolysin O activity are cytotoxic, avirulent, and unable to evade host extracellular defenses |
| Q37191263 | Listeria monocytogenes sigmaB modulates PrfA-mediated virulence factor expression |
| Q34996034 | Listeria monocytogenes virulence and pathogenicity, a food safety perspective |
| Q33975740 | Listeria pathogenesis and molecular virulence determinants |
| Q34797653 | Listeria-based vaccines can overcome tolerance by expanding low avidity CD8+ T cells capable of eradicating a solid tumor in a transgenic mouse model of cancer |
| Q37505374 | Listeriolysin O as a strong immunogenic molecule for the development of new anti-tumor vaccines |
| Q36313828 | Listeriolysin O secreted by Listeria monocytogenes into the host cell cytosol is degraded by the N-end rule pathway |
| Q41977863 | Listeriolysin O-induced membrane permeation mediates persistent interleukin-6 production in Caco-2 cells during Listeria monocytogenes infection in vitro. |
| Q90237966 | Listeriolysin O: A phagosome-specific cytolysin revisited |
| Q24672984 | Listeriolysin O: a genuine cytolysin optimized for an intracellular parasite |
| Q36506851 | Listeriolysin O: a key protein of Listeria monocytogenes with multiple functions |
| Q39384373 | Listeriolysin O: from bazooka to Swiss army knife. |
| Q28481377 | Listeriolysin o is strongly immunogenic independently of its cytotoxic activity |
| Q73892101 | Listeriolysin--a useful cytolysin |
| Q37843660 | Live, attenuated strains of Listeria and Salmonella as vaccine vectors in cancer treatment |
| Q38105337 | Live-attenuated Listeria-based immunotherapy. |
| Q35005263 | Macrophage intracellular signaling induced by Listeria monocytogenes |
| Q30155494 | Membrane assembly of the cholesterol-dependent cytolysin pore complex |
| Q54976030 | Molecular detection ofserotype groups of Listeria monocytogenes isolated from gallbladder of cattle and sheep in Iraq. |
| Q40955927 | Molecular docking based screening of Listeriolysin-O for improved inhibitors. |
| Q26864252 | Multifaceted activity of listeriolysin O, the cholesterol-dependent cytolysin of Listeria monocytogenes |
| Q37388716 | Multiple effector mechanisms induced by recombinant Listeria monocytogenes anticancer immunotherapeutics |
| Q35890636 | Nonclinical Development of BCG Replacement Vaccine Candidates |
| Q30363188 | Novel vaccination strategies against tuberculosis. |
| Q38076522 | Pathogenesis of listeriosis during pregnancy |
| Q37593055 | Phloretin Attenuates Listeria monocytogenes Virulence Both In vitro and In vivo by Simultaneously Targeting Listeriolysin O and Sortase A. |
| Q34488876 | Phosphorylation, ubiquitination and degradation of listeriolysin O in mammalian cells: role of the PEST-like sequence |
| Q33769189 | Pleiotropic enhancement of bacterial pathogenesis resulting from the constitutive activation of the Listeria monocytogenes regulatory factor PrfA. |
| Q36806339 | Processing of recombinant Listeria monocytogenes proteins for MHC class I presentation follows a dedicated, high-efficiency pathway |
| Q30361227 | Progress in tuberculosis vaccine development and host-directed therapies--a state of the art review. |
| Q37259634 | Promises and challenges for the development of Listeria monocytogenes-based immunotherapies |
| Q91789557 | Reactive oxygen species inhibits Listeria monocytogenes invasion into HepG2 epithelial cells |
| Q33846428 | Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor site |
| Q40252748 | Regulated translation of listeriolysin O controls virulence of Listeria monocytogenes |
| Q37552814 | RsbT and RsbV contribute to sigmaB-dependent survival under environmental, energy, and intracellular stress conditions in Listeria monocytogenes |
| Q39236463 | RsbV of Listeria monocytogenes contributes to regulation of environmental stress and virulence |
| Q34660987 | Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial |
| Q44053307 | Salmonella enterica serovar Typhimurium effector SigD/SopB is membrane-associated and ubiquitinated inside host cells |
| Q36667599 | Selective killing of HIV-1-positive macrophages and T cells by the Rev-dependent lentivirus carrying anthrolysin O from Bacillus anthracis |
| Q54784905 | Subtyping Listeria monocytogenes through the combined analyses of genotype and expression of the hlyA virulence determinant. |
| Q46519987 | Synergism between active listeriolysin O and dimethyldioctadecylammonium bromide to activate CD8(+) T cells |
| Q38202181 | The BCG replacement vaccine VPM1002: from drawing board to clinical trial |
| Q36324437 | The Listeria monocytogenes hemolysin has an acidic pH optimum to compartmentalize activity and prevent damage to infected host cells |
| Q64899489 | The Listeriolysin O PEST-like Sequence Co-opts AP-2-Mediated Endocytosis to Prevent Plasma Membrane Damage during Listeria Infection. |
| Q34774585 | The cell biology of Listeria monocytogenes infection: the intersection of bacterial pathogenesis and cell-mediated immunity |
| Q34398264 | The family of thiol-activated, cholesterol-binding cytolysins |
| Q34688688 | The multitalented pore-forming proteins of intracellular pathogens |
| Q37256589 | The posttranslocation chaperone PrsA2 contributes to multiple facets of Listeria monocytogenes pathogenesis |
| Q52543461 | The wheat cDNA LCT1 generates hypersensitivity to sodium in a salt-sensitive yeast strain. |
| Q24531317 | Use of RNA interference in Drosophila S2 cells to identify host pathways controlling compartmentalization of an intracellular pathogen |
| Q90345218 | Vaccination Against Tuberculosis: Revamping BCG by Molecular Genetics Guided by Immunology |
| Q26992233 | Vaccines against tuberculosis: where are we and where do we need to go? |
| Q58924835 | as a Vector for Cancer Immunotherapy: Current Understanding and Progress |
Search more.